|
CA2974651A1
(en)
|
2014-01-24 |
2015-07-30 |
Children's Hospital Of Eastern Ontario Research Institute Inc. |
Smc combination therapy for the treatment of cancer
|
|
US9732154B2
(en)
|
2014-02-28 |
2017-08-15 |
Janssen Biotech, Inc. |
Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia
|
|
US9603927B2
(en)
|
2014-02-28 |
2017-03-28 |
Janssen Biotech, Inc. |
Combination therapies with anti-CD38 antibodies
|
|
EA035979B1
(ru)
|
2014-09-09 |
2020-09-08 |
Янссен Байотек, Инк. |
Варианты комбинированной терапии анти-cd38 антителами
|
|
KR102597989B1
(ko)
|
2014-12-04 |
2023-11-02 |
얀센 바이오테크 인코포레이티드 |
급성 골수성 백혈병을 치료하기 위한 항-cd38 항체
|
|
IL319936A
(en)
|
2015-05-20 |
2025-05-01 |
Janssen Biotech Inc |
Anti-CD38 antibodies for the treatment of light chain amyloidosis and other CD38-positive hematological malignancies
|
|
WO2016209921A1
(en)
|
2015-06-22 |
2016-12-29 |
Janssen Biotech, Inc. |
Combination therapies for heme malignancies with anti-cd38 antibodies and survivin inhibitors
|
|
HRP20240338T1
(hr)
*
|
2015-06-24 |
2024-05-24 |
Janssen Biotech, Inc. |
Imunomodulacija i liječenje solidnih tumora s protutijelima koja se specifično vežu na cd38
|
|
US20170044265A1
(en)
|
2015-06-24 |
2017-02-16 |
Janssen Biotech, Inc. |
Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38
|
|
NZ739503A
(en)
*
|
2015-07-16 |
2023-06-30 |
Bioxcel Therapeutics Inc |
A novel approach for treatment of cancer using immunomodulation
|
|
US10781261B2
(en)
|
2015-11-03 |
2020-09-22 |
Janssen Biotech, Inc. |
Subcutaneous formulations of anti-CD38 antibodies and their uses
|
|
EP4516319A3
(en)
|
2015-11-03 |
2025-05-07 |
Janssen Biotech, Inc. |
Subcutaneous formulations of anti-cd38 antibodies and their uses
|
|
EP3442584B1
(en)
|
2016-03-15 |
2021-07-28 |
Seagen Inc. |
Combinations of pbd-based antibody drug conjugates with bcl-2 inhibitors
|
|
US11110179B2
(en)
|
2016-06-03 |
2021-09-07 |
Seagen Inc. |
Combination of CD33 antibody drug conjugates with chemotherapeutic agents
|
|
EP3469001A4
(en)
|
2016-06-09 |
2020-05-06 |
Seattle Genetics, Inc. |
COMBINATIONS OF PBD-BASED ANTIBODY CONJUGATES WITH FLT3 INHIBITORS
|
|
MA50514A
(fr)
|
2017-10-31 |
2020-09-09 |
Janssen Biotech Inc |
Méthodes de traitement du myélome multiple à haut risque
|
|
EP4084821A4
(en)
|
2020-01-03 |
2024-04-24 |
Marengo Therapeutics, Inc. |
Multifunctional molecules that bind to cd33 and uses thereof
|
|
US12213801B2
(en)
|
2020-10-02 |
2025-02-04 |
Cilag Gmbh International |
Surgical visualization and particle trend analysis system
|
|
US11992372B2
(en)
|
2020-10-02 |
2024-05-28 |
Cilag Gmbh International |
Cooperative surgical displays
|
|
US11830602B2
(en)
|
2020-10-02 |
2023-11-28 |
Cilag Gmbh International |
Surgical hub having variable interconnectivity capabilities
|
|
US11963683B2
(en)
|
2020-10-02 |
2024-04-23 |
Cilag Gmbh International |
Method for operating tiered operation modes in a surgical system
|
|
US12472032B2
(en)
|
2020-10-02 |
2025-11-18 |
Cilag Gmbh International |
Monitoring of user visual gaze to control which display system displays the primary information
|
|
US11748924B2
(en)
|
2020-10-02 |
2023-09-05 |
Cilag Gmbh International |
Tiered system display control based on capacity and user operation
|
|
US12064293B2
(en)
|
2020-10-02 |
2024-08-20 |
Cilag Gmbh International |
Field programmable surgical visualization system
|
|
US12016566B2
(en)
|
2020-10-02 |
2024-06-25 |
Cilag Gmbh International |
Surgical instrument with adaptive function controls
|
|
US11877897B2
(en)
|
2020-10-02 |
2024-01-23 |
Cilag Gmbh International |
Situational awareness of instruments location and individualization of users to control displays
|
|
US12484897B2
(en)
|
2020-10-02 |
2025-12-02 |
Cilag Gmbh International |
Surgical instrument with adaptive configuration control
|
|
US11672534B2
(en)
|
2020-10-02 |
2023-06-13 |
Cilag Gmbh International |
Communication capability of a smart stapler
|
|
CN116948029A
(zh)
|
2022-04-20 |
2023-10-27 |
南京融捷康生物科技有限公司 |
一种包含IgG类Fc区变体的抗体及其用途
|